abiraterone has been researched along with flufenamic acid in 1 studies
| Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (flufenamic acid) | Trials (flufenamic acid) | Recent Studies (post-2010) (flufenamic acid) |
|---|---|---|---|---|---|
| 942 | 97 | 854 | 1,058 | 69 | 202 |
| Protein | Taxonomy | abiraterone (IC50) | flufenamic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 0.76 | |
| Transthyretin | Homo sapiens (human) | 2.9 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.615 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.112 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.4901 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 1.3467 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 2.64 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonanni, D; Boschi, D; Carnovale, IM; Cena, C; Costale, A; Giraudo, A; Lolli, ML; Marini, E; Oliaro-Bosso, S; Pippione, AC; Pors, K; Sadiq, M; Zonari, D | 1 |
1 other study(ies) available for abiraterone and flufenamic acid
| Article | Year |
|---|---|
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2017 |